Article Details

Wheeler Bio Licenses ATUM's Proprietary Leap-In Transposase® Technology in Support of ...

Retrieved on: 2022-11-30 08:24:44

Tags for this article:

Click the tags to see associated articles and topics

Wheeler Bio Licenses ATUM's Proprietary Leap-In Transposase® Technology in Support of .... View article details on HISWAI: https://www.biospace.com/article/releases/wheeler-bio-licenses-atum-s-proprietary-leap-in-transposase-technology-in-support-of-its-disruptive-cdmo-service-offering/

Excerpt

Oren Beske, Ph.D., ATUM's Amalgamator of Business and Biology, commented, "The Leap-In platform is an excellent fit for Wheeler Bio's business model ...

Article found on: www.biospace.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up